APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Serialisation Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Serialisation Services Market Outlook and Growth Opportunities 2026

Report ID 174578960412 August 2026204 pages

Choose your research edition.

Industry ResearchPharmaceutical Serialisation Services Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Serialisation Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Serialisation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Serialisation Services Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Serialisation Services Market Analysis and Forecast 2026-2032186 pages · $4,950 USD

Market perspective

The global Pharmaceutical Serialisation Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Serialisation Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Serialisation Services market include Movianto, UPM Pharmaceuticals, MSK Pharmalogisti, Covectra, Koerber-Pharma, Palladio Group, TraceLink, Ultimate Solutions and Clarkston Consulting, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Serialisation Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Serialisation Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Serialisation Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Serialisation Services market.

Pharmaceutical Serialisation Services Segment by Company

Movianto

UPM Pharmaceuticals

MSK Pharmalogisti

Covectra

Koerber-Pharma

Palladio Group

TraceLink

Ultimate Solutions

Clarkston Consulting

Jones Healthcare Group

MSK Pharmalogistic

Vetter-Pharma

NextPharma Logistics

OPTEL

Central Pharma

Aphena Pharma +C581Solutions

NNE

Sharp Services

Pharmaceutical Serialisation Services Segment by Type

Barcode

QR Code

RFID

Others

Pharmaceutical Serialisation Services Segment by Application

Pharmaceutical Manufacturing

Pharmaceutical Distribution

Pharmaceutical Logistics

Pharmaceutical Serialisation Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Serialisation Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Serialisation Services key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Serialisation Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Serialisation Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Serialisation Services significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Serialisation Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Serialisation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Serialisation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Serialisation Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Serialisation Services industry.

Chapter 3: Detailed analysis of Pharmaceutical Serialisation Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Serialisation Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Serialisation Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Serialisation Services Industry Trends Table 2. Pharmaceutical Serialisation Services Industry Drivers Table 3. Pharmaceutical Serialisation Services Industry Opportunities and Challenges Table 4. Pharmaceutical Serialisation Services Industry Restraints Table 5. Global Pharmaceutical Serialisation Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Serialisation Services Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Serialisation Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Serialisation Services Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Serialisation Services Company, Product Type & Application Table 10. Global Pharmaceutical Serialisation Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Serialisation Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Barcode Table 15. Significant Companies of QR Code Table 16. Significant Companies of RFID Table 17. Significant Companies of Others Table 18. Global Pharmaceutical Serialisation Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical Serialisation Services Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical Serialisation Services Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Serialisation Services Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical Serialisation Services Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Manufacturing Table 24. Significant Companies of Pharmaceutical Distribution Table 25. Significant Companies of Pharmaceutical Logistics Table 26. Global Pharmaceutical Serialisation Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Serialisation Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Serialisation Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Serialisation Services Sales Value Share by Application (2021-2026) Table 30. Global Pharmaceutical Serialisation Services Sales Value Share by Application (2027-2032) Table 31. Global Pharmaceutical Serialisation Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Serialisation Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Serialisation Services Sales Value Share by Region (2021-2026) Table 34. Global Pharmaceutical Serialisation Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Serialisation Services Sales Value Share by Region (2027-2032) Table 36. Global Pharmaceutical Serialisation Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmaceutical Serialisation Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pharmaceutical Serialisation Services Sales Value Market Share by Country (2021-2026) Table 39. Global Pharmaceutical Serialisation Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical Serialisation Services Sales Value Market Share by Country (2027-2032) Table 41. Movianto Company Information Table 42. Movianto Business Overview Table 43. Movianto Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Movianto Pharmaceutical Serialisation Services Product Portfolio Table 45. Movianto Recent Development Table 46. UPM Pharmaceuticals Company Information Table 47. UPM Pharmaceuticals Business Overview Table 48. UPM Pharmaceuticals Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. UPM Pharmaceuticals Pharmaceutical Serialisation Services Product Portfolio Table 50. UPM Pharmaceuticals Recent Development Table 51. MSK Pharmalogisti Company Information Table 52. MSK Pharmalogisti Business Overview Table 53. MSK Pharmalogisti Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. MSK Pharmalogisti Pharmaceutical Serialisation Services Product Portfolio Table 55. MSK Pharmalogisti Recent Development Table 56. Covectra Company Information Table 57. Covectra Business Overview Table 58. Covectra Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Covectra Pharmaceutical Serialisation Services Product Portfolio Table 60. Covectra Recent Development Table 61. Koerber-Pharma Company Information Table 62. Koerber-Pharma Business Overview Table 63. Koerber-Pharma Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Koerber-Pharma Pharmaceutical Serialisation Services Product Portfolio Table 65. Koerber-Pharma Recent Development Table 66. Palladio Group Company Information Table 67. Palladio Group Business Overview Table 68. Palladio Group Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Palladio Group Pharmaceutical Serialisation Services Product Portfolio Table 70. Palladio Group Recent Development Table 71. TraceLink Company Information Table 72. TraceLink Business Overview Table 73. TraceLink Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. TraceLink Pharmaceutical Serialisation Services Product Portfolio Table 75. TraceLink Recent Development Table 76. Ultimate Solutions Company Information Table 77. Ultimate Solutions Business Overview Table 78. Ultimate Solutions Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Ultimate Solutions Pharmaceutical Serialisation Services Product Portfolio Table 80. Ultimate Solutions Recent Development Table 81. Clarkston Consulting Company Information Table 82. Clarkston Consulting Business Overview Table 83. Clarkston Consulting Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Clarkston Consulting Pharmaceutical Serialisation Services Product Portfolio Table 85. Clarkston Consulting Recent Development Table 86. Jones Healthcare Group Company Information Table 87. Jones Healthcare Group Business Overview Table 88. Jones Healthcare Group Pharmaceutical Serialisation Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Jones Healthcare Group Pharmaceutical Serialisation Services Product Portfolio Table 90. Jones Healthcare Group Recent Development Table 91. MSK Pharmalogistic Company Information Table 92. MSK Pharmalogistic Business Overview Table 93. MSK Pharmalogistic Pharmaceutical Serialisation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. MSK Pharmalogistic Pharmaceutical Serialisation Services Product Portfolio Table 95. MSK Pharmalogistic Recent Development Table 96. Vetter-Pharma Company Information Table 97. Vetter-Pharma Business Overview Table 98. Vetter-Pharma Pharmaceutical Serialisation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Vetter-Pharma Pharmaceutical Serialisation Services Product Portfolio Table 100. Vetter-Pharma Recent Development Table 101. NextPharma Logistics Company Information Table 102. NextPharma Logistics Business Overview Table 103. NextPharma Logistics Pharmaceutical Serialisation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. NextPharma Logistics Pharmaceutical Serialisation Services Product Portfolio Table 105. NextPharma Logistics Recent Development Table 106. OPTEL Company Information Table 107. OPTEL Business Overview Table 108. OPTEL Pharmaceutical Serialisation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. OPTEL Pharmaceutical Serialisation Services Product Portfolio Table 110. OPTEL Recent Development Table 111. Central Pharma Company Information Table 112. Central Pharma Business Overview Table 113. Central Pharma Pharmaceutical Serialisation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Central Pharma Pharmaceutical Serialisation Services Product Portfolio Table 115. Central Pharma Recent Development Table 116. Aphena Pharma +C581Solutions Company Information Table 117. Aphena Pharma +C581Solutions Business Overview Table 118. Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product Portfolio Table 120. Aphena Pharma +C581Solutions Recent Development Table 121. NNE Company Information Table 122. NNE Business Overview Table 123. NNE Pharmaceutical Serialisation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. NNE Pharmaceutical Serialisation Services Product Portfolio Table 125. NNE Recent Development Table 126. Sharp Services Company Information Table 127. Sharp Services Business Overview Table 128. Sharp Services Pharmaceutical Serialisation Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Sharp Services Pharmaceutical Serialisation Services Product Portfolio Table 130. Sharp Services Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Pharmaceutical Serialisation Services Product Image Figure 2. Global Pharmaceutical Serialisation Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Serialisation Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Barcode Image Figure 8. QR Code Image Figure 9. RFID Image Figure 10. Others Image Figure 11. Global Pharmaceutical Serialisation Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Serialisation Services Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Serialisation Services Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Manufacturing Image Figure 15. Pharmaceutical Distribution Image Figure 16. Pharmaceutical Logistics Image Figure 17. Global Pharmaceutical Serialisation Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Serialisation Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Serialisation Services Sales Value Share by Application (2021-2032) Figure 20. Global Pharmaceutical Serialisation Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pharmaceutical Serialisation Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pharmaceutical Serialisation Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical Serialisation Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pharmaceutical Serialisation Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pharmaceutical Serialisation Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pharmaceutical Serialisation Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pharmaceutical Serialisation Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pharmaceutical Serialisation Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pharmaceutical Serialisation Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pharmaceutical Serialisation Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pharmaceutical Serialisation Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Barcode
  • QR Code
  • RFID
  • Others
Applications
  • Pharmaceutical Manufacturing
  • Pharmaceutical Distribution
  • Pharmaceutical Logistics
Companies covered
  • Movianto
  • UPM Pharmaceuticals
  • MSK Pharmalogisti
  • Covectra
  • Koerber-Pharma
  • Palladio Group
  • TraceLink
  • Ultimate Solutions
  • Clarkston Consulting
  • Jones Healthcare Group
  • MSK Pharmalogistic
  • Vetter-Pharma
  • NextPharma Logistics
  • OPTEL
  • Central Pharma
  • Aphena Pharma +C581Solutions
  • NNE
  • Sharp Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Serialisation Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Serialisation Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Serialisation Services Market Dynamics
  1. 2.1 Pharmaceutical Serialisation Services Industry Trends
  2. 2.2 Pharmaceutical Serialisation Services Industry Drivers
  3. 2.3 Pharmaceutical Serialisation Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Serialisation Services Industry Restraints
3 Pharmaceutical Serialisation Services Market by Company
  1. 3.1 Global Pharmaceutical Serialisation Services Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Serialisation Services Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Serialisation Services Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Serialisation Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Serialisation Services Company Product Type and Application
  6. 3.6 Global Pharmaceutical Serialisation Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Serialisation Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Serialisation Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Serialisation Services Market by Type
  1. 4.1 Pharmaceutical Serialisation Services Type Introduction
  2. 4.1.1 Barcode
  3. 4.1.2 QR Code
  4. 4.1.3 RFID
  5. 4.1.4 Others
  6. 4.2 Global Pharmaceutical Serialisation Services Sales Value by Type
  7. 4.2.1 Global Pharmaceutical Serialisation Services Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Serialisation Services Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Serialisation Services Sales Value Share by Type (2021-2032)
5 Pharmaceutical Serialisation Services Market by Application
  1. 5.1 Pharmaceutical Serialisation Services Application Introduction
  2. 5.1.1 Pharmaceutical Manufacturing
  3. 5.1.2 Pharmaceutical Distribution
  4. 5.1.3 Pharmaceutical Logistics
  5. 5.2 Global Pharmaceutical Serialisation Services Sales Value by Application
  6. 5.2.1 Global Pharmaceutical Serialisation Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Serialisation Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Serialisation Services Sales Value Share by Application (2021-2032)
6 Pharmaceutical Serialisation Services Regional Value Analysis
  1. 6.1 Global Pharmaceutical Serialisation Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Serialisation Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Serialisation Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Serialisation Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Serialisation Services Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Serialisation Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Serialisation Services Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Serialisation Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Serialisation Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Serialisation Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Serialisation Services Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Serialisation Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Serialisation Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Serialisation Services Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Serialisation Services Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Serialisation Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Serialisation Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Serialisation Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Serialisation Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Serialisation Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Serialisation Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Serialisation Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Movianto
  2. 8.1.1 Movianto Company Information
  3. 8.1.2 Movianto Business Overview
  4. 8.1.3 Movianto Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Movianto Pharmaceutical Serialisation Services Product Portfolio
  6. 8.1.5 Movianto Recent Developments
  7. 8.2 UPM Pharmaceuticals
  8. 8.2.1 UPM Pharmaceuticals Company Information
  9. 8.2.2 UPM Pharmaceuticals Business Overview
  10. 8.2.3 UPM Pharmaceuticals Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 UPM Pharmaceuticals Pharmaceutical Serialisation Services Product Portfolio
  12. 8.2.5 UPM Pharmaceuticals Recent Developments
  13. 8.3 MSK Pharmalogisti
  14. 8.3.1 MSK Pharmalogisti Company Information
  15. 8.3.2 MSK Pharmalogisti Business Overview
  16. 8.3.3 MSK Pharmalogisti Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MSK Pharmalogisti Pharmaceutical Serialisation Services Product Portfolio
  18. 8.3.5 MSK Pharmalogisti Recent Developments
  19. 8.4 Covectra
  20. 8.4.1 Covectra Company Information
  21. 8.4.2 Covectra Business Overview
  22. 8.4.3 Covectra Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Covectra Pharmaceutical Serialisation Services Product Portfolio
  24. 8.4.5 Covectra Recent Developments
  25. 8.5 Koerber-Pharma
  26. 8.5.1 Koerber-Pharma Company Information
  27. 8.5.2 Koerber-Pharma Business Overview
  28. 8.5.3 Koerber-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Koerber-Pharma Pharmaceutical Serialisation Services Product Portfolio
  30. 8.5.5 Koerber-Pharma Recent Developments
  31. 8.6 Palladio Group
  32. 8.6.1 Palladio Group Company Information
  33. 8.6.2 Palladio Group Business Overview
  34. 8.6.3 Palladio Group Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Palladio Group Pharmaceutical Serialisation Services Product Portfolio
  36. 8.6.5 Palladio Group Recent Developments
  37. 8.7 TraceLink
  38. 8.7.1 TraceLink Company Information
  39. 8.7.2 TraceLink Business Overview
  40. 8.7.3 TraceLink Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 TraceLink Pharmaceutical Serialisation Services Product Portfolio
  42. 8.7.5 TraceLink Recent Developments
  43. 8.8 Ultimate Solutions
  44. 8.8.1 Ultimate Solutions Company Information
  45. 8.8.2 Ultimate Solutions Business Overview
  46. 8.8.3 Ultimate Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ultimate Solutions Pharmaceutical Serialisation Services Product Portfolio
  48. 8.8.5 Ultimate Solutions Recent Developments
  49. 8.9 Clarkston Consulting
  50. 8.9.1 Clarkston Consulting Company Information
  51. 8.9.2 Clarkston Consulting Business Overview
  52. 8.9.3 Clarkston Consulting Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Clarkston Consulting Pharmaceutical Serialisation Services Product Portfolio
  54. 8.9.5 Clarkston Consulting Recent Developments
  55. 8.10 Jones Healthcare Group
  56. 8.10.1 Jones Healthcare Group Company Information
  57. 8.10.2 Jones Healthcare Group Business Overview
  58. 8.10.3 Jones Healthcare Group Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jones Healthcare Group Pharmaceutical Serialisation Services Product Portfolio
  60. 8.10.5 Jones Healthcare Group Recent Developments
  61. 8.11 MSK Pharmalogistic
  62. 8.11.1 MSK Pharmalogistic Company Information
  63. 8.11.2 MSK Pharmalogistic Business Overview
  64. 8.11.3 MSK Pharmalogistic Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MSK Pharmalogistic Pharmaceutical Serialisation Services Product Portfolio
  66. 8.11.5 MSK Pharmalogistic Recent Developments
  67. 8.12 Vetter-Pharma
  68. 8.12.1 Vetter-Pharma Company Information
  69. 8.12.2 Vetter-Pharma Business Overview
  70. 8.12.3 Vetter-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vetter-Pharma Pharmaceutical Serialisation Services Product Portfolio
  72. 8.12.5 Vetter-Pharma Recent Developments
  73. 8.13 NextPharma Logistics
  74. 8.13.1 NextPharma Logistics Company Information
  75. 8.13.2 NextPharma Logistics Business Overview
  76. 8.13.3 NextPharma Logistics Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 NextPharma Logistics Pharmaceutical Serialisation Services Product Portfolio
  78. 8.13.5 NextPharma Logistics Recent Developments
  79. 8.14 OPTEL
  80. 8.14.1 OPTEL Company Information
  81. 8.14.2 OPTEL Business Overview
  82. 8.14.3 OPTEL Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 OPTEL Pharmaceutical Serialisation Services Product Portfolio
  84. 8.14.5 OPTEL Recent Developments
  85. 8.15 Central Pharma
  86. 8.15.1 Central Pharma Company Information
  87. 8.15.2 Central Pharma Business Overview
  88. 8.15.3 Central Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Central Pharma Pharmaceutical Serialisation Services Product Portfolio
  90. 8.15.5 Central Pharma Recent Developments
  91. 8.16 Aphena Pharma +C581Solutions
  92. 8.16.1 Aphena Pharma +C581Solutions Company Information
  93. 8.16.2 Aphena Pharma +C581Solutions Business Overview
  94. 8.16.3 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product Portfolio
  96. 8.16.5 Aphena Pharma +C581Solutions Recent Developments
  97. 8.17 NNE
  98. 8.17.1 NNE Company Information
  99. 8.17.2 NNE Business Overview
  100. 8.17.3 NNE Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 NNE Pharmaceutical Serialisation Services Product Portfolio
  102. 8.17.5 NNE Recent Developments
  103. 8.18 Sharp Services
  104. 8.18.1 Sharp Services Company Information
  105. 8.18.2 Sharp Services Business Overview
  106. 8.18.3 Sharp Services Pharmaceutical Serialisation Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sharp Services Pharmaceutical Serialisation Services Product Portfolio
  108. 8.18.5 Sharp Services Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst